Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the ...

Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ...

MODERNA has won the latest round of its long-running legal battle with Pfizer and its German partner BioNTech over its Covid ...

Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a ...

NEW YORK (Reuters) – Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key ...

London: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and ...

The European Patent Office last week upheld one of Moderna’s key patents, handing the biotech an important victory in its ...

Then $75 per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial.

The COVID-19 vaccine is currently being contested between Moderna Pfizer (PFE.N), which opens a new tab, and BioNTech ...

In December 2023, the EPO invalidated the ‘565 patent which protects respiratory virus vaccines. Litigation over the patents ...

It was a week of patent cases going to trial in the pharmaceutical industry. Pfizer, AstraZeneca, and Moderna all were ...

Moderna is nearing a deal with the US government to fund a late-stage trial of its bird flu vaccine, the Financial Times ...